Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival

Although esophageal cancer has a poor prognosis after recurrence, some patients have shown long‐term survival despite recurrence. We hypothesized that induction of either antitumor Abs or antitumor‐specific CTLs could play a role in long‐term survival (5 years or longer) in patients with recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi‐Maeda, Sayaka, Yajima, Satoshi, Suzuki, Takashi, Usami, Katsuaki, Takahashi, Nobuaki, Niwa, Rinpei, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207364/
https://www.ncbi.nlm.nih.gov/pubmed/35348270
http://dx.doi.org/10.1111/cas.15350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207364/
https://www.ncbi.nlm.nih.gov/pubmed/35348270
http://dx.doi.org/10.1111/cas.15350

Ejemplares similares